Publications by authors named "Fode Camara"
Artificial Intelligence approaches to predict COVID-19 infection in Senegal.
Procedia Comput Sci
April 2022
The SARS-CoV2 virus, which causes COVID-19 (coronavirus disease) has become a pandemic and has expanded all over the world. Because of increasing number of cases day by day, it takes time to interpret the data thus the limitations in terms of both treatment and findings are emerged. Due to such limitations, the need for clinical decisions making system with predictive algorithms has arisen.
View Article and Find Full Text PDFCorrection: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
Daouda Sissoko Cedric Laouenan Elin Folkesson Abdoul-Bing M'Lebing Abdoul-Habib Beavogui Alseny-Modet Camara Mohamed Seto Camara Diarra Camara Fodé Saydou Camara
PLoS Med
April 2016
[This corrects the article DOI: 10.1371/journal.pmed.
View Article and Find Full Text PDFExperimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
Daouda Sissoko Cedric Laouenan Elin Folkesson Abdoul-Bing M'Lebing Abdoul-Habib Beavogui Alseny-Modet Camara Mohamed Seto Camara Diarra Camara Fodé Saydou Camara
PLoS Med
March 2016
Article Synopsis
- Ebola virus disease (EVD) is highly fatal, and during the 2014 outbreak, the WHO identified favipiravir as a potential treatment, but ethical concerns prevented randomized trials.
- Instead, a multicenter non-randomized trial was conducted where all patients received favipiravir to assess its feasibility, safety, and effectiveness in treating EVD.
- Participants were selected based on specific criteria and received a set dosage of favipiravir, with the goal of gathering preliminary data to inform future research rather than establish definitive treatment guidelines.